Search Results - "Katia Fassina"

TKI Treatment Discontinuation: How Many Patients Could Stop Tyrosine Kinase Treatment According to Discontinuation Trials Criteria? Incidence and Prognostic Impact of Deep Molecular Response in a Cohort of Chronic Myeloid Leukemia Patients of South Brazil’s Hematology Centers by Fogliatto, Laura, Capra, Marcelo Eduardo Zanella, Shaan, Mariza, Vanelli Costa, Tito, Contin, Luis Carlos Zanandrea, Breunig, Raquel, Silveira, Juarez Fontoura, Torriani, Mayde Seadi, Fassina, Katia, Fernandes, Mario Sergio, Almeida, Denise, Schilling, Marco Antonio, Hellwig, Tânia, Daltoe, Tiago, Moschen, Mariangela, Zardo, Adriana, Nene, Moema, Daudt, Liane Esteves, Friedrisch, João, Silla, Lucia

“…Sustained deep molecular response (MR4.5) after imatinib treatment defines a subgroup of patients with chronic myeloid leukemia (CML) with better outcome and…”
Get full text

The Impact of Early Molecular Response in Event Free Survival in Patients with Chronic Myeloid Leukemia Treated with Imatinib by Fogliatto, Laura, Capra, Marcelo Eduardo Zanella, Shaan, Mariza, Costa, Tito Vanelli, Torriani, Mayde Seadi, Contin, Luis Carlos Zanandrea, Breunig, Raquel, Fassina, Katia, Fernandes, Mario Sérgio, Almeida, Denise, Schilling, Marco Antônio, Hellwig, Tânia, Daltoe, Tiago, Zardo, Adriana, Moschen, Mariangela, Nene, Moema, Silveira, Juarez Fontoura, Soares, Tahiane Brum, Daudt, Liane Esteves, Friedrisch, João, Silla, Lucia

“…Background Monitoring response to TKI therapy is one of the key management strategies of chronic myeloid leukemia (CML). Early molecular response to first-line…”
Get full text

Prospective study of strongyloidosis in patients with hematologic malignancies by Graeff-Teixeira, C, Leite, C S, Sperhacke, C L, Fassina, K, Petry, S M, Mucenic, T, Pandolfi, C, Barcellos, S, Job, F

“…Immunocompromised individuals infected with Strongyloides stercoralis may develop severe hyperinfection or disseminated disease with high mortality. Patients…”
Get full text

The Impact of Cytogenetic Response At 6 Months of Therapy in Global Survival of Patients with Chronic Myeloid Leukemia Treated with Imatinib in the South of Brazil by Fogliatto, Laura, Capra, Marcelo, Schaan, Mariza, Fernandes, Mario Sérgio, Costa, Tito Vanelli, Torriani, Mayde Seadi, Fassina, Katia, Fraga, Christina G S, Baron, Mayla, Koshiyama, Dayane, Machado, Natássia, Daudt, Liane Esteves, Silla, Lucia

“…Abstract 4453 Treatment of chronic myeloid leukemia with imatinib leads to disease remission in a majority of patient, but in some patients (pts) controlling…”
Get full text

Warning As Defiened By European Leukemia Net 2013 (ELN 2013) In Chronic Phase Chronic Myeloid Leukemia (CP-CML) Corresponds To Warning In The Clinical Practice? by Fogliatto, Laura, Capra, Marcelo, Shaan, Mariza, Costa, Tito Vanelli, Breunig, Raquel, Fraga, Christina G S, Torriani, Mayde Seadi, Silla, Lucia, Daudt, Liane Esteves, Fernandes, Mario Sérgio, Almeida, Denise, Schilling, Marco Antônio, Hellwig, Tânia, Fassina, Katia, Wisintainer, Sabrina, Moschen, Mariangela, Daltoe, Tiago, Zardo, Adriana, Kratochvil, Juliana, Fernandes, Viviane Magagnin, Eickhoff, Cheila, Nene, Moema, Ahmad, Saozan, Almeida, Andréia Dias, Lenz, Vitor

“…Treatment of chronic myeloid leukemia with imatinib leads to disease remission in a majority of patients (pts), but in a subgroup of pts controlling the…”
Get full text

Important Role of Early Therapy and Maintaining Uninterrupted Treatment In the Outcomes of Chronic Myelogenous Leukemia Patients Treated with Imatinib by Ottoni, Erica Lammerhirt, Capra, Marcelo, Schaan, Mariza, Schilling, Marco Antônio, Fassina, Katia, Fernandes, Mario Sérgio, Almeida, Denise, Nene, Moema, Hellwig, Tânia, Costa, Tito Vanelli, Zardo, Adriana, Almeida, Andréia Dias, Nachtigal, Gilca, Fraga, Christina G S, Daudt, Liane Esteves, Silla, Lucia, Fogliatto, Laura

“…Abstract 2300 Imatinib mesylate (Gleevec) treatment for Chronic Myelogenous Leukemia (CML) was first introduced in Brazil in 2003, initially used as second…”
Get full text

Impact of Comorbidity In Event-Free Survival, Toxicity and Adherence to Treatment In Chronic Myeloid Leukemia Patients Treated with Imatinib by Fogliatto, Laura, Capra, Marcelo, Schaan, Mariza, Fassina, Katia, Fernandes, Mario Sérgio, Schilling, Marco Antônio, Almeida, Denise, Nene, Moema, Hellwig, Tânia, Nachtigal, Gilca, João, Adriana Zardo, Almeida, Andréia Dias, Costa, Tito Vanelli, Ottoni, Erica Lammerhirt, Fraga, Christina G S, Daudt, Liane Esteves, Silla, Lucia

“…Abstract 2296 Comorbidity in cancer has been shown to be a major determinant in treatment selection and survival. The most used instrument for measuring…”
Get full text

Results of Imatinib Therapy In Patients with Early and Late Chronic-Phase Chronic Myeloid Leukemia In a South Brazilian Cohort by Capra, Marcelo, Shaan, Mariza, Fassina, Katia, Fernandes, Mario Sérgio, Schilling, Marco Antônio, Almeida, Denise, Nene, Moema, Hellwig, Tânia, Nachtigal, Gilca, Zardo, Adriana, Almeida, Andréia Dias, Costa, Tito Vanelli, Ottoni, Erica Lammerhirt, Torriani, Mayde Seadi, Fraga, Christina G S, Daudt, Liane Esteves, Silla, Lucia, Fogliatto, Laura

“…Abstract 4487 Imatinib treatment for Chronic Myeloid Leukemia (CML) was first introduced in Brazil in 2001, initially used as second line therapy for patients…”
Get full text

The Role of Early Cytogenetic Response in Patients with Chronic Myeloid Leukemia Treated with Imatinib and the Impact of Adherence and Comorbidities by Fogliatto, Laura, Capra, Marcelo, Shaan, Mariza, Costa, Tito Vanelli, Torriani, Mayde Seadi, Fassina, Katia, Fernandes, Mario Sérgio, Almeida, Denise, Schilling, Marco Antônio, Hellwig, Tânia, Coser, Virgínia, Pereira, Dalnei Veiga, Pereira, Waldir Veiga, Wisintainer, Sabrina, Daltoe, Tiago, Moschen, Mariangela, Zardo, Adriana, Kratochvil, Juliana, Fernandes, Viviane Magagnin, Eickhoff, Cheila, Ahmad, Saozan, Almeida, Andréia Dias, Nene, Moema, Xavier, Nathália Guterres, Koshiyama, Dayane, Leite, Márcia, Lenz, Vitor, Daudt, Liane Esteves, Silla, Lucia

“…Abstract 4423 Treatment of chronic myeloid leukemia with imatinib leads to disease remission in a majority of patient, but in some patients (pts) controlling…”
Get full text

Determinants and Impact of Treatment Interruptions and Nonadherence to Imatinib Therapy in Patients with Chronic Myeloid Leukemia in a South Brazilian Cohort by Capra, Marcelo, Fogliatto, Laura, Shaan, Mariza, Torriani, Mayde Seadi, Costa, Tito Vanelli, Fernandes, Mario Sérgio, Fassina, Katia, Almeida, Denise, Schilling, Marco Antônio, Hellwig, Tânia, Coser, Virgínia, Pereira, Dalnei Veiga, Pereira, Waldir Veiga, Moschen, Mariangela, Daltoe, Tiago, Wisintainer, Sabrina, Eickhoff, Cheila, Fernandes, Viviane Magagnin, Kratochvil, Juliana, Ahmad, Saozan, Zardo, Adriana, Almeida, Andréia Dias, Lenz, Vitor, Leite, Márcia, Nene, Moema, Koshiyama, Dayane, Xavier, Nathália Guterres, Daudt, Liane Esteves, Silla, Lucia

“…Abstract 4425 Adherence to imatinib therapy has proven to be a major determinant of treatment results, but the degree of impact and the determinants of…”
Get full text

Trombocitose essencial: o que é essencial saber by Bittencourt, Rosane I., Poncelet, Karin, Almeida, Antonio Carlos C., Fassina, Katia, Onsten, Tor G.

Get full text

Trombocitose essencial: o que é essencial saber Essential thrombocytosis: what is vital to know by Rosane I. Bittencourt, Karin Poncelet, Antonio Carlos C. Almeida, Katia Fassina, Tor G. Onsten

“…A trombocitose essencial (TE) faz parte do grupo de síndromes mieloproliferativas (SMP) cromossomo Philadelphia(Ph) negativas. Caracteriza-se pela…”
Get full text

Trombocitose essencial: o que é essencial saber by Bittencourt, Rosane I., Poncelet, Karin, Almeida, Antonio Carlos C., Fassina, Katia, Onsten, Tor G.

“…A trombocitose essencial (TE) faz parte do grupo de síndromes mieloproliferativas (SMP) cromossomo Philadelphia(Ph) negativas. Caracteriza-se pela…”
Get full text

Leucemia Mielóide Agura: perfil de duas décadas do Serviço de Hematologia do Hospital das Clínicas de Porto Alegre - RS by Bittencourt, Rosane, Fogliato, Laura, Daudt, Liane, Bittencourt, Henrique N. S., Friederich, João R., Fernandes, Flavo, Onsten, Tor, Fassina, Kátia, Rocha, Luis K. da, Moreno, Fábio, Silva, Geórgia, Cruz, Matheus S., Garcia, Régis G. de, Wasnievski, João C., Silla, Lúcia M. R.

“…Nos últimos vinte anos, nosso serviço recebeu os pacientes com a suspeita de Leucemia Mielóide Aguda (LMA) provenientes de todas as regiões do estado. Entre…”
Get full text